These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2837231)

  • 1. SCH 28080 is a lumenally acting, K+-site inhibitor of the gastric (H+ + K+)-ATPase.
    Keeling DJ; Laing SM; Senn-Bilfinger J
    Biochem Pharmacol; 1988 Jun; 37(11):2231-6. PubMed ID: 2837231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SK&F 96067 is a reversible, lumenally acting inhibitor of the gastric (H+ + K+)-ATPase.
    Keeling DJ; Malcolm RC; Laing SM; Ife RJ; Leach CA
    Biochem Pharmacol; 1991 Jun; 42(1):123-30. PubMed ID: 1648919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of a K(+)-competitive inhibitor, a substituted imidazo[1,2a] pyridine, with the phospho- and dephosphoenzyme forms of H+, K(+)-ATPase.
    Mendlein J; Sachs G
    J Biol Chem; 1990 Mar; 265(9):5030-6. PubMed ID: 2156860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The binding of a K+ competitive ligand, 2-methyl,8-(phenylmethoxy)imidazo(1,2-a)pyridine 3-acetonitrile, to the gastric (H+ + K+)-ATPase.
    Keeling DJ; Taylor AG; Schudt C
    J Biol Chem; 1989 Apr; 264(10):5545-51. PubMed ID: 2538422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SCH 28080 is a more selective inhibitor than SCH 32651 at the K+ site of gastric K+/H+-ATPase.
    Beil W; Staar U; Sewing KF
    Eur J Pharmacol; 1987 Jul; 139(3):349-52. PubMed ID: 2822435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of gastric H+/K+-ATPase by substituted imidazo[1,2-a]pyridines.
    Briving C; Andersson BM; Nordberg P; Wallmark B
    Biochim Biophys Acta; 1988 Dec; 946(2):185-92. PubMed ID: 2850003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of gastric antisecretory effect of SCH 28080.
    Beil W; Hackbarth I; Sewing KF
    Br J Pharmacol; 1986 May; 88(1):19-23. PubMed ID: 3011171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of gastric H+,K+-ATPase and acid secretion by SCH 28080, a substituted pyridyl(1,2a)imidazole.
    Wallmark B; Briving C; Fryklund J; Munson K; Jackson R; Mendlein J; Rabon E; Sachs G
    J Biol Chem; 1987 Feb; 262(5):2077-84. PubMed ID: 3029064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of H+K+ATPase by SCH 28080 and SCH 32651.
    Scott CK; Sundell E
    Eur J Pharmacol; 1985 Jun; 112(2):268-70. PubMed ID: 2993001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiulcer agents. 5. Inhibition of gastric H+/K(+)-ATPase by substituted imidazo[1,2-a]pyridines and related analogues and its implication in modeling the high affinity potassium ion binding site of the gastric proton pump enzyme.
    Kaminski JJ; Wallmark B; Briving C; Andersson BM
    J Med Chem; 1991 Feb; 34(2):533-41. PubMed ID: 1847427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of H+/K(+)-ATPase by inorganic phosphate. The role of K+ and SCH 28080.
    Van der Hijden HT; Koster HP; Swarts HG; De Pont JJ
    Biochim Biophys Acta; 1991 Jan; 1061(2):141-8. PubMed ID: 1847826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of the reversible K(+)-competitive inhibitor of the gastric (H+/K+)-ATPase, SK&F 97574. I. In vitro activity.
    Pope AJ; Boehm MK; Leach C; Ife RJ; Keeling D; Parsons ME
    Biochem Pharmacol; 1995 Nov; 50(10):1543-9. PubMed ID: 7503755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oleic acid as an inhibitor of gastric H+, K(+)-ATPase.
    Murakami S; Muramatsu M; Otomo S
    Res Commun Chem Pathol Pharmacol; 1991 Mar; 71(3):337-50. PubMed ID: 1646470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the mechanism of action of the gastric microsomal (H+ + K+)-ATPase inhibitors SCH 32651 and SCH 28080.
    Scott CK; Sundell E; Castrovilly L
    Biochem Pharmacol; 1987 Jan; 36(1):97-104. PubMed ID: 3026407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pH on the interaction of ligands with the (H+ + K+)-ATPase purified from pig gastric mucosa.
    Ljungström M; Vega FV; Mårdh S
    Biochim Biophys Acta; 1984 Jan; 769(1):220-30. PubMed ID: 6318823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the gastric (H+ + K+)-ATPase by fenoctimine.
    Reenstra WW; Shortridge B; Forte JG
    Biochem Pharmacol; 1985 Jul; 34(13):2331-4. PubMed ID: 2990481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric H+-K+-ATPase in situ: relation to secretory state.
    Hersey SJ; Steiner L; Matheravidathu S; Sachs G
    Am J Physiol; 1988 Jun; 254(6 Pt 1):G856-63. PubMed ID: 2837098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of H+,K+-ATPase by a K+-competitive photoaffinity inhibitor.
    Munson KB; Sachs G
    Biochemistry; 1988 May; 27(11):3932-8. PubMed ID: 2843221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Cl- channel in hog gastric vesicles is part of the function of H,K-ATPase.
    Asano S; Inoie M; Takeguchi N
    J Biol Chem; 1987 Sep; 262(27):13263-8. PubMed ID: 2443490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of gastric H+,K(+)-ATPase by the anti-ulcer agent, sofalcone.
    Murakami S; Muramatsu M; Aihara H; Otomo S
    Biochem Pharmacol; 1991 Sep; 42(7):1447-51. PubMed ID: 1656986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.